Pub Date : 2025-12-17Epub Date: 2025-11-26DOI: 10.1128/msystems.01185-25
John B O'Connor, Jennifer Fouquier, Charles P Neff, John D Sterrett, Tyson Marden, Suzanne Fiorillo, Janet C Siebert, Jennifer Schneider, Nichole Nusbacher, Amy T Noe, Blair Fennimore, Janine Higgins, Thomas B Campbell, Brent E Palmer, Catherine Lozupone
This study aimed to assess the impact of a high-fiber/low-fat agrarian diet (AD) on inflammation and metabolic outcomes in HIV-positive men who have sex with men (MSM). Since the gut microbiomes of MSM resemble those of individuals in agrarian cultures, including being Prevotella-rich and Bacteroides-poor, we hypothesized that they would have particularly strong health benefits from consumption of a diet matched to their microbiome type. Sixty-six participants, including 36 HIV-positive MSM [HIV(+)MSM], 21 HIV-negative MSM, and 9 HIV-negative men who have sex with women, were randomized to either an AD or a high-fat/low-fiber western diet (WD) for 4 weeks. Plasma, fecal, and colonic biopsy samples were obtained. Metabolic and inflammatory markers were measured in plasma. 16S ribosomal RNA sequencing was performed on fecal and biopsy samples, and shotgun metagenomic sequencing was performed on fecal samples. The AD reduced plasma low-density lipoprotein cholesterol (LDL-C) in HIV(+)MSM, with median reductions of 0.4138 mmoL/L at 2 weeks and 0.2845 mmol/L at 4 weeks. Greater LDL-C reductions were predicted by Prevotella-rich/Bacteroides-poor microbiomes with increased starch utilization potential, emphasizing the importance of personalized microbiome-dietary matching. The AD also reduced T cell exhaustion and pro-inflammatory intermediate monocytes and altered host transcription in the colonic mucosa.
Importance: Our findings suggest tailoring diet interventions to baseline microbiome types can promote metabolic health in Prevotella-rich/Bacteroides-poor MSM, a significant portion of people living with HIV at risk for metabolic syndrome.This study was registered at NCT02610374.
{"title":"Agrarian diet improves metabolic health in HIV-positive men with <i>Prevotella</i>-rich microbiomes: results from a randomized trial.","authors":"John B O'Connor, Jennifer Fouquier, Charles P Neff, John D Sterrett, Tyson Marden, Suzanne Fiorillo, Janet C Siebert, Jennifer Schneider, Nichole Nusbacher, Amy T Noe, Blair Fennimore, Janine Higgins, Thomas B Campbell, Brent E Palmer, Catherine Lozupone","doi":"10.1128/msystems.01185-25","DOIUrl":"10.1128/msystems.01185-25","url":null,"abstract":"<p><p>This study aimed to assess the impact of a high-fiber/low-fat agrarian diet (AD) on inflammation and metabolic outcomes in HIV-positive men who have sex with men (MSM). Since the gut microbiomes of MSM resemble those of individuals in agrarian cultures, including being <i>Prevotella</i>-rich and <i>Bacteroides</i>-poor, we hypothesized that they would have particularly strong health benefits from consumption of a diet matched to their microbiome type. Sixty-six participants, including 36 HIV-positive MSM [HIV(+)MSM], 21 HIV-negative MSM, and 9 HIV-negative men who have sex with women, were randomized to either an AD or a high-fat/low-fiber western diet (WD) for 4 weeks. Plasma, fecal, and colonic biopsy samples were obtained. Metabolic and inflammatory markers were measured in plasma. 16S ribosomal RNA sequencing was performed on fecal and biopsy samples, and shotgun metagenomic sequencing was performed on fecal samples. The AD reduced plasma low-density lipoprotein cholesterol (LDL-C) in HIV(+)MSM, with median reductions of 0.4138 mmoL/L at 2 weeks and 0.2845 mmol/L at 4 weeks. Greater LDL-C reductions were predicted by <i>Prevotella</i>-rich/<i>Bacteroides</i>-poor microbiomes with increased starch utilization potential, emphasizing the importance of personalized microbiome-dietary matching. The AD also reduced T cell exhaustion and pro-inflammatory intermediate monocytes and altered host transcription in the colonic mucosa.</p><p><strong>Importance: </strong>Our findings suggest tailoring diet interventions to baseline microbiome types can promote metabolic health in <i>Prevotella</i>-rich/<i>Bacteroides</i>-poor MSM, a significant portion of people living with HIV at risk for metabolic syndrome.This study was registered at NCT02610374.</p>","PeriodicalId":18819,"journal":{"name":"mSystems","volume":" ","pages":"e0118525"},"PeriodicalIF":4.6,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12710365/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145605044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Investigating microbiome subnetworks and identifying central microbes in specific ecological niches is a critical issue in human microbiome studies. Traditional methods typically require control samples, limiting the ability to study microbiomes at distinct body sites without matched controls. Moreover, some clustering methods are not well-suited for microbial data and fail to identify central subcommunities across ecological niches after clustering. In this study, we present MNetClass, a novel microbial network clustering analysis framework. It utilizes a random walk algorithm and a rank-sum ratio-entropy weight evaluation model to classify key subnetworks and identify central microbes at any body site, without the need for control samples. We demonstrate its capabilities on both simulated and real microbiome data sets. Simulation results indicate that MNetClass outperforms current unsupervised microbial clustering methods. In applied case studies, the analysis of microbiome data from five distinct oral sites revealed site-specific microbial communities. Furthermore, MNetClass demonstrated superior predictive performance on cross-cohort Autism Spectrum Disorder data and identified age-related microbial communities across different oral sites, underscoring its broad applicability in microbiome research.IMPORTANCEMNetClass provides a valuable tool for microbiome network analysis, enabling the identification of key microbial subcommunities across diverse ecological niches. Implemented as an R package (https://github.com/YihuaWWW/MNetClass), it offers broad accessibility for researchers. Here, we systematically benchmarked MNetClass against existing microbial clustering methods on synthetic data using various performance metrics, demonstrating its superior efficacy. Notably, MNetClass operates without the need for control groups and effectively identifies central microbes, highlighting its potential as a robust framework for advancing microbiome research.
{"title":"MNetClass: a control-free microbial network clustering framework for identifying central subcommunities across ecological niches.","authors":"Yihua Wang, Qingzhen Hou, Fulan Wei, Bingqiang Liu, Qiang Feng","doi":"10.1128/msystems.00989-25","DOIUrl":"10.1128/msystems.00989-25","url":null,"abstract":"<p><p>Investigating microbiome subnetworks and identifying central microbes in specific ecological niches is a critical issue in human microbiome studies. Traditional methods typically require control samples, limiting the ability to study microbiomes at distinct body sites without matched controls. Moreover, some clustering methods are not well-suited for microbial data and fail to identify central subcommunities across ecological niches after clustering. In this study, we present MNetClass, a novel microbial network clustering analysis framework. It utilizes a random walk algorithm and a rank-sum ratio-entropy weight evaluation model to classify key subnetworks and identify central microbes at any body site, without the need for control samples. We demonstrate its capabilities on both simulated and real microbiome data sets. Simulation results indicate that MNetClass outperforms current unsupervised microbial clustering methods. In applied case studies, the analysis of microbiome data from five distinct oral sites revealed site-specific microbial communities. Furthermore, MNetClass demonstrated superior predictive performance on cross-cohort Autism Spectrum Disorder data and identified age-related microbial communities across different oral sites, underscoring its broad applicability in microbiome research.IMPORTANCEMNetClass provides a valuable tool for microbiome network analysis, enabling the identification of key microbial subcommunities across diverse ecological niches. Implemented as an R package (https://github.com/YihuaWWW/MNetClass), it offers broad accessibility for researchers. Here, we systematically benchmarked MNetClass against existing microbial clustering methods on synthetic data using various performance metrics, demonstrating its superior efficacy. Notably, MNetClass operates without the need for control groups and effectively identifies central microbes, highlighting its potential as a robust framework for advancing microbiome research.</p>","PeriodicalId":18819,"journal":{"name":"mSystems","volume":" ","pages":"e0098925"},"PeriodicalIF":4.6,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12710344/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145541354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-17Epub Date: 2025-11-12DOI: 10.1128/msystems.01112-25
Aaron C Ericsson, Zachary L McAdams, Rebecca A Dorfmeyer, Marcia L Hart, Armedia O'Neill-Blair, James Amos-Landgraf, Craig L Franklin
Studies using genetically engineered mouse (GEM) models are often performed over extended periods. The microbiomes of GEM colonies are expected to retain some of the microbial features present in the founder mice used to generate each GEM model and to acquire new features through dietary and environmental sources. The rate at which these processes occur over time likely varies between institutions. To assess the relative effect size of environment on the microbiome of GEMs used in biomedical research, we performed 16S rRNA metabarcoding of fecal samples from 275 distinct GEM lines (n = 351) maintained by 139 different laboratories at 84 different research institutions in 34 U.S. states or districts and seven other countries, and compared intra-strain, inter-strain, inter-lab, and inter-institution similarities. Reference data from mice harboring supplier-origin (SO) microbiomes (n = 1,171) were used to determine the relative contribution and nature of microbes from known and unknown sources. Paradoxically, the data indicate that the immediate laboratory-level environment is the dominant factor shaping the microbiome of GEM models, but that the microbiome of GEMs develops similarities in beta-diversity, regardless of other factors. Related to this, we detected an unexpectedly high prevalence and abundance of Helicobacter spp. in GEM microbiomes, the abundance of which correlated significantly with the abundance of multiple resident taxa colonizing the mucosa. These findings suggest a higher prevalence of Helicobacter spp. in laboratory mice than previously appreciated, and the possibility of positive and negative interactions with other taxa is found to affect GEM model phenotypes.IMPORTANCEThere are concerns regarding the reproducibility and predictive value of mouse models of human disease. Notwithstanding those legitimate concerns, genetically engineered mouse (GEM) models provide an invaluable platform to investigate gene function or effects of environmental factors in a biological system. The microbiome of GEM models significantly influences model phenotypes and thus represents a possible source of poor reproducibility. While the microbiome is often incorporated in research investigating disease mechanisms using GEMs, limited information is available regarding the similarity of the microbiome of GEM models within and between research labs at the same institution, or across institutions. Moreover, while the microbiome of founder mice from different suppliers is known to differ, the degree to which features present in supplier-origin microbiomes are retained in GEM colonies throughout experimentation is unclear. These data demonstrate the robust effect of lab-level environment and the need for sample collection concurrent with phenotyping.
{"title":"Dominant effects of the immediate environment on the gut microbiome of mice used in biomedical research.","authors":"Aaron C Ericsson, Zachary L McAdams, Rebecca A Dorfmeyer, Marcia L Hart, Armedia O'Neill-Blair, James Amos-Landgraf, Craig L Franklin","doi":"10.1128/msystems.01112-25","DOIUrl":"10.1128/msystems.01112-25","url":null,"abstract":"<p><p>Studies using genetically engineered mouse (GEM) models are often performed over extended periods. The microbiomes of GEM colonies are expected to retain some of the microbial features present in the founder mice used to generate each GEM model and to acquire new features through dietary and environmental sources. The rate at which these processes occur over time likely varies between institutions. To assess the relative effect size of environment on the microbiome of GEMs used in biomedical research, we performed 16S rRNA metabarcoding of fecal samples from 275 distinct GEM lines (<i>n</i> = 351) maintained by 139 different laboratories at 84 different research institutions in 34 U.S. states or districts and seven other countries, and compared intra-strain, inter-strain, inter-lab, and inter-institution similarities. Reference data from mice harboring supplier-origin (SO) microbiomes (<i>n</i> = 1,171) were used to determine the relative contribution and nature of microbes from known and unknown sources. Paradoxically, the data indicate that the immediate laboratory-level environment is the dominant factor shaping the microbiome of GEM models, but that the microbiome of GEMs develops similarities in beta-diversity, regardless of other factors. Related to this, we detected an unexpectedly high prevalence and abundance of <i>Helicobacter</i> spp. in GEM microbiomes, the abundance of which correlated significantly with the abundance of multiple resident taxa colonizing the mucosa. These findings suggest a higher prevalence of <i>Helicobacter</i> spp. in laboratory mice than previously appreciated, and the possibility of positive and negative interactions with other taxa is found to affect GEM model phenotypes.IMPORTANCEThere are concerns regarding the reproducibility and predictive value of mouse models of human disease. Notwithstanding those legitimate concerns, genetically engineered mouse (GEM) models provide an invaluable platform to investigate gene function or effects of environmental factors in a biological system. The microbiome of GEM models significantly influences model phenotypes and thus represents a possible source of poor reproducibility. While the microbiome is often incorporated in research investigating disease mechanisms using GEMs, limited information is available regarding the similarity of the microbiome of GEM models within and between research labs at the same institution, or across institutions. Moreover, while the microbiome of founder mice from different suppliers is known to differ, the degree to which features present in supplier-origin microbiomes are retained in GEM colonies throughout experimentation is unclear. These data demonstrate the robust effect of lab-level environment and the need for sample collection concurrent with phenotyping.</p>","PeriodicalId":18819,"journal":{"name":"mSystems","volume":" ","pages":"e0111225"},"PeriodicalIF":4.6,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12710307/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145496450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-17Epub Date: 2025-11-17DOI: 10.1128/msystems.01269-25
J M Carpentier, S A P Derocles, S Chéreau, B Marquer, J Linglin, L Lebreton, F Legeai, N Vannier, A M Cortesero, C Mougel
Plant secondary metabolites are key mediators of plant-insect-microbiome interactions, yet their role in structuring functionally relevant insect-associated microbial communities remains poorly understood. Here, we combined a factorial experiment using Brassica napus genotypes differing in glucosinolate (GLS) content with distinct succession to investigate the eco-evolutionary dynamics of the microbiota of the root herbivore Delia radicum. Amplicon sequencing and microbial culturing revealed that both rhizospheric and gut microbial communities are shaped by plant genotype and soil legacy, with a subset of bacterial taxa shared across compartments. Notably, Pseudomonas brassicacearum, harboring the isothiocyanates (ITC) detoxifying gene saxA, was consistently recovered from both plant and insect habitats. Functional assays confirmed its capacity to degrade 2-phenylethyl isothiocyanate (PEITC), a major toxic GLS hydrolysis product. Other gut-derived microbial isolates exhibited heterogeneous responses to PEITC, ranging from growth inhibition, promotion, or growth recovery after a prolonged lag phase. Despite the toxicity of ITC, insect fitness proxies were enhanced on GLS +plants, suggesting microbiota-mediated adaptation to host chemical defenses. Our findings reveal a plant genotype-specific filtering of environmentally acquired microbes and highlight the role of detoxifying symbionts in Delia radicum performance.IMPORTANCEUnderstanding how herbivorous insects adapt to plant chemical defenses is important in the context of new agricultural practices. This study highlights that the host plant genotype shapes not only rhizospheric and gut microbial communities but also promotes the acquisition of symbiotic bacteria capable of detoxifying harmful isothiocyanates. These findings reveal a functional microbial pathway for insect adaptation to plant defenses, with potential implications for pest management strategies. By uncovering the role of plant-associated microbiota, the acquisition of beneficial microbes, and their functional contributions to host fitness, this work provides a foundation for innovative agroecological approaches that leverage plant-microbe-insect interactions.
{"title":"Contrasting glucosinolate profiles in rapeseed genotypes shape the rhizosphere-insect continuum and microbial detoxification potential in a root herbivore.","authors":"J M Carpentier, S A P Derocles, S Chéreau, B Marquer, J Linglin, L Lebreton, F Legeai, N Vannier, A M Cortesero, C Mougel","doi":"10.1128/msystems.01269-25","DOIUrl":"10.1128/msystems.01269-25","url":null,"abstract":"<p><p>Plant secondary metabolites are key mediators of plant-insect-microbiome interactions, yet their role in structuring functionally relevant insect-associated microbial communities remains poorly understood. Here, we combined a factorial experiment using <i>Brassica napus</i> genotypes differing in glucosinolate (GLS) content with distinct succession to investigate the eco-evolutionary dynamics of the microbiota of the root herbivore <i>Delia radicum</i>. Amplicon sequencing and microbial culturing revealed that both rhizospheric and gut microbial communities are shaped by plant genotype and soil legacy, with a subset of bacterial taxa shared across compartments. Notably, <i>Pseudomonas brassicacearum</i>, harboring the isothiocyanates (ITC) detoxifying gene <i>saxA</i>, was consistently recovered from both plant and insect habitats. Functional assays confirmed its capacity to degrade 2-phenylethyl isothiocyanate (PEITC), a major toxic GLS hydrolysis product. Other gut-derived microbial isolates exhibited heterogeneous responses to PEITC, ranging from growth inhibition, promotion, or growth recovery after a prolonged lag phase. Despite the toxicity of ITC, insect fitness proxies were enhanced on GLS +plants, suggesting microbiota-mediated adaptation to host chemical defenses. Our findings reveal a plant genotype-specific filtering of environmentally acquired microbes and highlight the role of detoxifying symbionts in <i>Delia radicum</i> performance.IMPORTANCEUnderstanding how herbivorous insects adapt to plant chemical defenses is important in the context of new agricultural practices. This study highlights that the host plant genotype shapes not only rhizospheric and gut microbial communities but also promotes the acquisition of symbiotic bacteria capable of detoxifying harmful isothiocyanates. These findings reveal a functional microbial pathway for insect adaptation to plant defenses, with potential implications for pest management strategies. By uncovering the role of plant-associated microbiota, the acquisition of beneficial microbes, and their functional contributions to host fitness, this work provides a foundation for innovative agroecological approaches that leverage plant-microbe-insect interactions.</p>","PeriodicalId":18819,"journal":{"name":"mSystems","volume":" ","pages":"e0126925"},"PeriodicalIF":4.6,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12710311/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145541381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-17Epub Date: 2025-11-12DOI: 10.1128/msystems.00932-25
Wenwen Liu, Komei Nagasaka, Junyi Wu, Hiroki Ban, Ethan Mimick, Lingjie Meng, Russell Y Neches, Mohammad Moniruzzaman, Takashi Yoshida, Yosuke Nishimura, Hisashi Endo, Yusuke Okazaki, Hiroyuki Ogata
Giant viruses (GVs) of the phyla Nucleocytoviricota and Mirusviricota are large double-stranded DNA viruses that infect diverse eukaryotic hosts and impact biogeochemical cycles. Their diversity and ecological roles have been well studied in the photic layer of the ocean, but less is known about their activity, population dynamics, and adaptive strategies in the aphotic layers. Here, we conducted eight seasonal time-series samplings of the surface and mesopelagic layers at a coastal site in Muroto, Japan, and integrated 18S metabarcoding, metagenomic, and metatranscriptomic data to investigate mesopelagic GVs and their potential hosts. The analysis identified 48 GV genomes including six that were exclusively detected in the mesopelagic layer. Notably, these mesopelagic-specific GVs showed persistent activity across seasons. To further investigate the distribution and phylogenomic features of GVs at a global scale across broader depths, we compiled 4,473 species-level GV genomes from the OceanDNA MAG project and other resources and analyzed 1,890 marine metagenomes. This revealed 101 deep-sea-specific GVs, distributed across the GV phylogenetic tree, indicating that adaptation to deep-sea environments has occurred in multiple lineages. One clade enriched with deep-sea-specific GVs included a GV genome identified in our Muroto data, which displayed a wide geographic distribution. Seventy-six KEGG orthologs and 74 Pfam domains were specifically enriched in deep-sea-specific GVs, encompassing functions related to the ubiquitin system, energy metabolism, and nitrogen acquisition. These findings support the scenario that distinct GV lineages have adapted to hosts in aphotic marine environments by altering their gene repertoire to thrive in this unique habitat.IMPORTANCEGiant viruses are widespread in the ocean surface and are key in shaping marine ecosystems by infecting phytoplankton and other protists. However, little is known about their activity and adaptive strategies in deep-sea environments. In this study, we performed metagenomic and metatranscriptomic analyses of seawater samples collected from a coastal site in Japan and discovered giant virus genomes showing persistent transcriptional activity across seasons in the mesopelagic water. Using a global marine data set, we further uncovered geographically widespread and vertically extensive groups of deep-sea-specific giant viruses and characterized their distinctive gene repertoire, which likely facilitates adaptation to the limited availability of light and organic compounds in the aphotic zone. These findings expand our understanding of giant virus ecology in the dark ocean.
{"title":"Giant viruses specific to deep oceans show persistent presence and activity.","authors":"Wenwen Liu, Komei Nagasaka, Junyi Wu, Hiroki Ban, Ethan Mimick, Lingjie Meng, Russell Y Neches, Mohammad Moniruzzaman, Takashi Yoshida, Yosuke Nishimura, Hisashi Endo, Yusuke Okazaki, Hiroyuki Ogata","doi":"10.1128/msystems.00932-25","DOIUrl":"10.1128/msystems.00932-25","url":null,"abstract":"<p><p>Giant viruses (GVs) of the phyla <i>Nucleocytoviricota</i> and <i>Mirusviricota</i> are large double-stranded DNA viruses that infect diverse eukaryotic hosts and impact biogeochemical cycles. Their diversity and ecological roles have been well studied in the photic layer of the ocean, but less is known about their activity, population dynamics, and adaptive strategies in the aphotic layers. Here, we conducted eight seasonal time-series samplings of the surface and mesopelagic layers at a coastal site in Muroto, Japan, and integrated 18S metabarcoding, metagenomic, and metatranscriptomic data to investigate mesopelagic GVs and their potential hosts. The analysis identified 48 GV genomes including six that were exclusively detected in the mesopelagic layer. Notably, these mesopelagic-specific GVs showed persistent activity across seasons. To further investigate the distribution and phylogenomic features of GVs at a global scale across broader depths, we compiled 4,473 species-level GV genomes from the OceanDNA MAG project and other resources and analyzed 1,890 marine metagenomes. This revealed 101 deep-sea-specific GVs, distributed across the GV phylogenetic tree, indicating that adaptation to deep-sea environments has occurred in multiple lineages. One clade enriched with deep-sea-specific GVs included a GV genome identified in our Muroto data, which displayed a wide geographic distribution. Seventy-six KEGG orthologs and 74 Pfam domains were specifically enriched in deep-sea-specific GVs, encompassing functions related to the ubiquitin system, energy metabolism, and nitrogen acquisition. These findings support the scenario that distinct GV lineages have adapted to hosts in aphotic marine environments by altering their gene repertoire to thrive in this unique habitat.IMPORTANCEGiant viruses are widespread in the ocean surface and are key in shaping marine ecosystems by infecting phytoplankton and other protists. However, little is known about their activity and adaptive strategies in deep-sea environments. In this study, we performed metagenomic and metatranscriptomic analyses of seawater samples collected from a coastal site in Japan and discovered giant virus genomes showing persistent transcriptional activity across seasons in the mesopelagic water. Using a global marine data set, we further uncovered geographically widespread and vertically extensive groups of deep-sea-specific giant viruses and characterized their distinctive gene repertoire, which likely facilitates adaptation to the limited availability of light and organic compounds in the aphotic zone. These findings expand our understanding of giant virus ecology in the dark ocean.</p>","PeriodicalId":18819,"journal":{"name":"mSystems","volume":" ","pages":"e0093225"},"PeriodicalIF":4.6,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12710325/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145496399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-17Epub Date: 2025-11-04DOI: 10.1128/msystems.00803-25
Jinny Wu Yang, Vincent J Denef
<p><p>Microbial symbionts play vital roles in the health, fitness, and ecological dynamics of most eukaryotic species, making it essential to understand how host-microbe interactions shape the microbiome. Building on our previous work, we hypothesized that symbionts with diverse functions are maintained in the microbiome via a trade-off between two host-microbe interaction modes: either by better utilizing host-derived dissolved organic matter (DOM) without direct interaction with the host (unidirectional interaction) or by engaging in feedback interactions with the host that alter DOM composition to their advantage (bidirectional interaction). By screening symbionts isolated from <i>C. sorokiniana</i> (host), we examined growth and gene expression responses of two representative symbionts and the host. We found <i>Curvibacter</i> sp. thrived on spent medium from axenic <i>C. sorokiniana</i> with host-derived dissolved organic matter (DOM) in unidirectional interaction, whereas <i>Falsiroseomonas</i> sp. grew best with live <i>C. sorokiniana</i> cells in bidirectional interaction and exhibited a greater shift in gene expression between modes despite larger growth phase differences between treatments for <i>Curvibacter</i> sp. Specifically, <i>Falsiroseomonas</i> sp. showed differential expression of metabolic pathways that could benefit (e.g., synthesis of cofactors) or antagonize (e.g., metabolism of defensive secondary metabolites) toward the host under bidirectional interaction conditions. In response, host co-cultured with <i>Falsiroseomonas</i> sp. reduced its growth and triggered its higher expression of nitrogen-rich amino acid metabolism which may provide a nutritional benefit to <i>Falsiroseomonas</i> sp. These findings demonstrated that distinct host-microbe interaction modes drive differential symbiont strategies and play an important role in microbiome assembly.</p><p><strong>Importance: </strong>Deciphering how host-microbe interactions shape microbiome structure is crucial for understanding host health and ecosystem function. Given the inherent complexity of host-microbe interactions, we simplified the system by separating interactions into unidirectional and bidirectional modes. Using this framework, we observed contrasting effects on the growth of two representative bacterial taxa isolated from the same host microbiome. These growth responses were further coupled with distinctive gene expression profiles in both hosts and bacteria under the different interaction modes. Together, these findings underscore the importance of considering host-microbe interaction modes in microbiome research. For example, our findings help explain how hosts can harbor functionally diverse microbial assemblages, where contrasting metabolic strategies are maintained through distinct interaction modes. Such insights are fundamental for predicting, managing, or engineering microbiomes, as well as understanding the ecological processes that drive microbiome
{"title":"Dissecting two contrasting phytoplankton-symbiont interaction modes based on population dynamics and gene expression patterns.","authors":"Jinny Wu Yang, Vincent J Denef","doi":"10.1128/msystems.00803-25","DOIUrl":"10.1128/msystems.00803-25","url":null,"abstract":"<p><p>Microbial symbionts play vital roles in the health, fitness, and ecological dynamics of most eukaryotic species, making it essential to understand how host-microbe interactions shape the microbiome. Building on our previous work, we hypothesized that symbionts with diverse functions are maintained in the microbiome via a trade-off between two host-microbe interaction modes: either by better utilizing host-derived dissolved organic matter (DOM) without direct interaction with the host (unidirectional interaction) or by engaging in feedback interactions with the host that alter DOM composition to their advantage (bidirectional interaction). By screening symbionts isolated from <i>C. sorokiniana</i> (host), we examined growth and gene expression responses of two representative symbionts and the host. We found <i>Curvibacter</i> sp. thrived on spent medium from axenic <i>C. sorokiniana</i> with host-derived dissolved organic matter (DOM) in unidirectional interaction, whereas <i>Falsiroseomonas</i> sp. grew best with live <i>C. sorokiniana</i> cells in bidirectional interaction and exhibited a greater shift in gene expression between modes despite larger growth phase differences between treatments for <i>Curvibacter</i> sp. Specifically, <i>Falsiroseomonas</i> sp. showed differential expression of metabolic pathways that could benefit (e.g., synthesis of cofactors) or antagonize (e.g., metabolism of defensive secondary metabolites) toward the host under bidirectional interaction conditions. In response, host co-cultured with <i>Falsiroseomonas</i> sp. reduced its growth and triggered its higher expression of nitrogen-rich amino acid metabolism which may provide a nutritional benefit to <i>Falsiroseomonas</i> sp. These findings demonstrated that distinct host-microbe interaction modes drive differential symbiont strategies and play an important role in microbiome assembly.</p><p><strong>Importance: </strong>Deciphering how host-microbe interactions shape microbiome structure is crucial for understanding host health and ecosystem function. Given the inherent complexity of host-microbe interactions, we simplified the system by separating interactions into unidirectional and bidirectional modes. Using this framework, we observed contrasting effects on the growth of two representative bacterial taxa isolated from the same host microbiome. These growth responses were further coupled with distinctive gene expression profiles in both hosts and bacteria under the different interaction modes. Together, these findings underscore the importance of considering host-microbe interaction modes in microbiome research. For example, our findings help explain how hosts can harbor functionally diverse microbial assemblages, where contrasting metabolic strategies are maintained through distinct interaction modes. Such insights are fundamental for predicting, managing, or engineering microbiomes, as well as understanding the ecological processes that drive microbiome","PeriodicalId":18819,"journal":{"name":"mSystems","volume":" ","pages":"e0080325"},"PeriodicalIF":4.6,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12710304/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145438616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Global regulators (GRs) are key transcription factors that orchestrate the expression of multiple genes, playing essential roles in stress responses, virulence, secondary metabolism, and antibiotic resistance-traits that make them powerful tools for synthetic biology applications. However, conventional approaches often fail to detect remote homologs and novel GR types, limiting our understanding of their regulatory diversity and evolutionary dynamics across prokaryotes. Here, we present a large-scale, protein language model-driven framework to systematically chart the global regulatory landscape across 14,800 bacterial and archaeal type strain genomes-the most taxonomically diverse prokaryotic data set analyzed to date. Using a deep learning-based GR identification model trained on 74,872 curated GR sequences, we systematically identified over 270,000 GR-like proteins, including 173,256 homologs of 214 experimentally validated GR types, 52 putative GR types, and 76,113 proteins of unknown function. This model demonstrated high sensitivity and generalization capability, enabling the discovery of remote homologs and cryptic regulators beyond the reach of similarity- or domain-based methods. This expanded GR catalog revealed lineage-specific distribution patterns, functionally diverse regulons with both conserved and niche-specific targets, and hierarchical cross-regulatory networks with shared and phylum-enriched hubs. By unveiling the hidden diversity and evolutionary structure of prokaryotic global regulators, this landscape of GRs provides foundational insights into microbial gene regulation and offers a powerful toolkit for the rational design of tunable, modular, and orthogonal genetic circuits in synthetic biology.IMPORTANCEGRs are master transcriptional regulators critical for microbial adaptation, stress tolerance, and metabolic control, and they serve as valuable components for synthetic biology. However, a comprehensive understanding of GR diversity and function across the prokaryotic domain has remained elusive due to the limitations of traditional detection methods. In this study, we developed a deep learning-based identification framework and applied it to 14,800 bacterial and archaeal type strain genomes, resulting in the discovery of over 270,000 GR-like proteins, including dozens of novel types. This work provides a comprehensive landscape of prokaryotic global regulators, revealing lineage-specific distribution patterns, both conserved and specialized regulons, and modular cross-regulatory network architectures. These insights not only deepen our understanding of transcriptional regulation in microbial evolution and ecology but also provide a scalable resource for the rational design of regulatory systems in synthetic biology.
{"title":"Unveiling the landscape of prokaryotic global regulators through deep protein language models.","authors":"Jianing Geng, Jiang Wu, Sainan Luo, Dongmei Liu, Jingyi Nie, Guomei Fan, Qinglan Sun, Songnian Hu, Linhuan Wu","doi":"10.1128/msystems.00950-25","DOIUrl":"10.1128/msystems.00950-25","url":null,"abstract":"<p><p>Global regulators (GRs) are key transcription factors that orchestrate the expression of multiple genes, playing essential roles in stress responses, virulence, secondary metabolism, and antibiotic resistance-traits that make them powerful tools for synthetic biology applications. However, conventional approaches often fail to detect remote homologs and novel GR types, limiting our understanding of their regulatory diversity and evolutionary dynamics across prokaryotes. Here, we present a large-scale, protein language model-driven framework to systematically chart the global regulatory landscape across 14,800 bacterial and archaeal type strain genomes-the most taxonomically diverse prokaryotic data set analyzed to date. Using a deep learning-based GR identification model trained on 74,872 curated GR sequences, we systematically identified over 270,000 GR-like proteins, including 173,256 homologs of 214 experimentally validated GR types, 52 putative GR types, and 76,113 proteins of unknown function. This model demonstrated high sensitivity and generalization capability, enabling the discovery of remote homologs and cryptic regulators beyond the reach of similarity- or domain-based methods. This expanded GR catalog revealed lineage-specific distribution patterns, functionally diverse regulons with both conserved and niche-specific targets, and hierarchical cross-regulatory networks with shared and phylum-enriched hubs. By unveiling the hidden diversity and evolutionary structure of prokaryotic global regulators, this landscape of GRs provides foundational insights into microbial gene regulation and offers a powerful toolkit for the rational design of tunable, modular, and orthogonal genetic circuits in synthetic biology.IMPORTANCEGRs are master transcriptional regulators critical for microbial adaptation, stress tolerance, and metabolic control, and they serve as valuable components for synthetic biology. However, a comprehensive understanding of GR diversity and function across the prokaryotic domain has remained elusive due to the limitations of traditional detection methods. In this study, we developed a deep learning-based identification framework and applied it to 14,800 bacterial and archaeal type strain genomes, resulting in the discovery of over 270,000 GR-like proteins, including dozens of novel types. This work provides a comprehensive landscape of prokaryotic global regulators, revealing lineage-specific distribution patterns, both conserved and specialized regulons, and modular cross-regulatory network architectures. These insights not only deepen our understanding of transcriptional regulation in microbial evolution and ecology but also provide a scalable resource for the rational design of regulatory systems in synthetic biology.</p>","PeriodicalId":18819,"journal":{"name":"mSystems","volume":" ","pages":"e0095025"},"PeriodicalIF":4.6,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12710356/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145588120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-17Epub Date: 2025-11-06DOI: 10.1128/msystems.00954-25
Soomin Lee, Shahbaz Raza, Eun-Ju Lee, Yoosoo Chang, Seungho Ryu, Hyung-Lae Kim, Si-Hyuck Kang, Han-Na Kim
<p><p>Gut microbiota has emerged as a critical factor influencing cardiovascular disease (CVD) risk, particularly coronary artery disease (CAD) development. Using fecal metagenomic shotgun sequencing, we investigated gut microbiota signatures associated with CAD and provided strain-resolved insights through metagenome-assembled genome (MAG) reconstruction. We analyzed 14 patients with CAD and 28 propensity score-matched healthy controls. Differential abundance analysis identified 15 CAD-associated bacterial species. Members of the <i>Lachnospiraceae</i> family, previously associated with trimethylamine-N-oxide production, were significantly enriched in patients with CAD. Conversely, short-chain fatty acid-producing bacteria <i>Slackia isoflavoniconvertens</i> and <i>Faecalibacterium prausnitzii</i> were depleted, suggesting a potential contribution to gut-mediated inflammation and metabolic dysregulation. Metabolic pathway analysis revealed significant urea cycle and L-citrulline biosynthesis enrichment in CAD cases, with <i>Alistipes</i> and <i>Coprococcus</i> as key contributors. Among predicted metabolites, inosine, which is implicated in coronary artery relaxation, was elevated in patients with CAD, whereas C18:0e MAG and α-muricholate were depleted. A random forest model achieved a mean AUC of 0.89 for CAD classification, with improved performance when integrating microbial taxa and metabolites. CAD-derived MAGs showed metabolic signatures linked to inflammatory dysbiosis and cardiovascular dysfunction, such as enriched N<sub>2</sub> fixation and sulfite reduction. Strain-resolved comparative genomic analysis of MAGs revealed distinctive functional characteristics between CAD-derived and control-derived strains of <i>Akkermansia muciniphila</i> and <i>Megamonas fumiformis. F. prausnitzii</i> MAG from the control group carried non-trimethylamine-producing gene, <i>mtxB</i>, suggesting its potential protective role in CAD pathophysiology. These findings provide insights into gut microbial alterations in CAD and highlight potential targets for microbiome-based therapeutic interventions to reduce CVD risk.IMPORTANCEGut microbiota plays a pivotal role in cardiovascular disease; however, its specific contribution to coronary artery disease (CAD) remains underexplored. This study identified distinct microbial signatures associated with CAD, including the enrichment of pro-inflammatory bacterial taxa and depletion of short-chain fatty acid-producing bacteria, which may contribute to systemic inflammation and metabolic dysregulation. Perturbations in key pathways, such as the urea cycle and glycolysis, suggest metabolic links between the gut microbiota and CAD. Additionally, the metagenome-assembled genome-based analysis revealed strain-resolved functional heterogeneity that shapes host-microbe interactions and may contribute to CAD pathophysiology. These findings provide novel insights into gut dysbiosis in CAD and highlight the potential of microbi
肠道微生物群已成为影响心血管疾病(CVD)风险的关键因素,特别是冠状动脉疾病(CAD)的发展。利用粪便宏基因组霰弹枪测序,我们研究了与CAD相关的肠道微生物群特征,并通过宏基因组组装基因组(MAG)重建提供了菌株解析的见解。我们分析了14例CAD患者和28例倾向评分匹配的健康对照。差异丰度分析鉴定出15种cad相关细菌。以前与三甲胺- n -氧化物产生有关的毛缕菌科成员在CAD患者中显著富集。相反,短链脂肪酸产生细菌松弛异黄酮和Faecalibacterium prausnitzii被消耗,这表明它们可能导致肠道介导的炎症和代谢失调。代谢途径分析显示,CAD病例中尿素循环和l -瓜氨酸生物合成富集显著,其中Alistipes和Coprococcus是主要贡献者。在预测的代谢物中,与冠状动脉舒张有关的肌苷在冠心病患者中升高,而C18:0e MAG和α-鼠酸盐则减少。随机森林模型用于CAD分类的平均AUC为0.89,在整合微生物分类群和代谢物时性能有所提高。cad衍生的mag显示了与炎症生态失调和心血管功能障碍相关的代谢特征,如丰富的N2固定和亚硫酸盐还原。菌株解析的MAGs比较基因组分析揭示了cad衍生菌株和对照衍生菌株之间的不同功能特征。对照组的F. prausnitzii MAG携带非三甲胺产生基因mtxB,提示其在CAD病理生理中具有潜在的保护作用。这些发现为CAD的肠道微生物改变提供了见解,并突出了基于微生物组的治疗干预以降低心血管疾病风险的潜在靶点。肠道菌群在心血管疾病中起关键作用;然而,其对冠状动脉疾病(CAD)的具体作用仍未得到充分研究。该研究确定了与CAD相关的不同微生物特征,包括促炎细菌类群的富集和短链脂肪酸产生细菌的消耗,这可能导致全身性炎症和代谢失调。关键途径的扰动,如尿素循环和糖酵解,表明肠道微生物群与CAD之间的代谢联系。此外,基于宏基因组组装的基因组分析揭示了菌株解决功能异质性,形成宿主-微生物相互作用,并可能有助于CAD病理生理。这些发现为CAD中的肠道生态失调提供了新的见解,并突出了精准医学中针对微生物组的治疗策略的潜力。
{"title":"Metagenome-assembled genomes reveal microbial signatures and metabolic pathways linked to coronary artery disease.","authors":"Soomin Lee, Shahbaz Raza, Eun-Ju Lee, Yoosoo Chang, Seungho Ryu, Hyung-Lae Kim, Si-Hyuck Kang, Han-Na Kim","doi":"10.1128/msystems.00954-25","DOIUrl":"10.1128/msystems.00954-25","url":null,"abstract":"<p><p>Gut microbiota has emerged as a critical factor influencing cardiovascular disease (CVD) risk, particularly coronary artery disease (CAD) development. Using fecal metagenomic shotgun sequencing, we investigated gut microbiota signatures associated with CAD and provided strain-resolved insights through metagenome-assembled genome (MAG) reconstruction. We analyzed 14 patients with CAD and 28 propensity score-matched healthy controls. Differential abundance analysis identified 15 CAD-associated bacterial species. Members of the <i>Lachnospiraceae</i> family, previously associated with trimethylamine-N-oxide production, were significantly enriched in patients with CAD. Conversely, short-chain fatty acid-producing bacteria <i>Slackia isoflavoniconvertens</i> and <i>Faecalibacterium prausnitzii</i> were depleted, suggesting a potential contribution to gut-mediated inflammation and metabolic dysregulation. Metabolic pathway analysis revealed significant urea cycle and L-citrulline biosynthesis enrichment in CAD cases, with <i>Alistipes</i> and <i>Coprococcus</i> as key contributors. Among predicted metabolites, inosine, which is implicated in coronary artery relaxation, was elevated in patients with CAD, whereas C18:0e MAG and α-muricholate were depleted. A random forest model achieved a mean AUC of 0.89 for CAD classification, with improved performance when integrating microbial taxa and metabolites. CAD-derived MAGs showed metabolic signatures linked to inflammatory dysbiosis and cardiovascular dysfunction, such as enriched N<sub>2</sub> fixation and sulfite reduction. Strain-resolved comparative genomic analysis of MAGs revealed distinctive functional characteristics between CAD-derived and control-derived strains of <i>Akkermansia muciniphila</i> and <i>Megamonas fumiformis. F. prausnitzii</i> MAG from the control group carried non-trimethylamine-producing gene, <i>mtxB</i>, suggesting its potential protective role in CAD pathophysiology. These findings provide insights into gut microbial alterations in CAD and highlight potential targets for microbiome-based therapeutic interventions to reduce CVD risk.IMPORTANCEGut microbiota plays a pivotal role in cardiovascular disease; however, its specific contribution to coronary artery disease (CAD) remains underexplored. This study identified distinct microbial signatures associated with CAD, including the enrichment of pro-inflammatory bacterial taxa and depletion of short-chain fatty acid-producing bacteria, which may contribute to systemic inflammation and metabolic dysregulation. Perturbations in key pathways, such as the urea cycle and glycolysis, suggest metabolic links between the gut microbiota and CAD. Additionally, the metagenome-assembled genome-based analysis revealed strain-resolved functional heterogeneity that shapes host-microbe interactions and may contribute to CAD pathophysiology. These findings provide novel insights into gut dysbiosis in CAD and highlight the potential of microbi","PeriodicalId":18819,"journal":{"name":"mSystems","volume":" ","pages":"e0095425"},"PeriodicalIF":4.6,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12710354/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145452384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-17Epub Date: 2025-11-13DOI: 10.1128/msystems.01384-25
Jun Seok Cha, Kyungnam Kim, Hwa Jeong You, Dasom Kim, Hyun Hee Park, SuJin Heo, Choon Ok Kim, Byung Hak Jin, Dongeun Yong, Dongwoo Chae
<p><p>Bacteriophages are emerging as promising alternatives to antibiotics for multidrug-resistant (MDR) infections. However, their unique pharmacokinetic and pharmacodynamic (PKPD) properties arising from host-dependent amplification present challenges for dose selection and clinical translation. Here, we present a mechanistic PKPD model informed by <i>in vitro</i> kinetic assays and <i>in vivo</i> mouse studies of phage therapy targeting MDR <i>Pseudomonas aeruginosa</i>. The model extends the classical predator-prey model by addressing dormancy-related bacterial persistence and partitioning bacterial subpopulations based on phage susceptibility profiles. Simulations revealed a non-monotonous dose-exposure curve driven by dose-dependent reduction of phage replication and the importance of cross-resistance in selecting optimal phage cocktails. <i>In vivo</i>, host immunity was identified as a crucial component in inhibiting bacterial regrowth, with bistable outcomes dependent on initial bacterial load and immune competence. Dose-ranging simulations under varying immune statuses suggest that long-term bacterial load is solely determined by host immune function. However, higher doses transiently reduce bacterial load to a greater extent and thereby suppress immune activation. In immunocompetent hosts, phage cocktails can enhance maximal bacterial load reduction when administered at doses higher than a critical threshold. In conclusion, our PKPD framework enables optimal selection of phage cocktails and dosing regimens, supports rational design of first-in-human trials of phage therapy, and potentially advances model-informed drug development for replication-competent biologics.IMPORTANCEIn this study, we construct an integrative model of phage-bacteria dynamics and investigate whether its calibration to <i>in vitro</i> kinetic assay data can inform the rational design of phage therapy regimens and cocktails. Our findings demonstrate a dose range within which lower phage doses yield higher long-term exposure, presenting a fundamentally different framework for dose optimization. Analysis of phage cocktails reveals that combining phages with low cross-resistance delays the regrowth of phage-resistant bacteria <i>in vitro</i>. The extended <i>in vivo</i> model elucidates key differences between <i>in vitro</i> and <i>in vivo</i> outcomes and highlights the importance of the host's immune response in suppressing the growth of phage-resistant bacteria. Phage cocktails to combat phage resistance are therefore of less importance in immune-competent individuals but can enhance bacterial killing when administered at sufficiently high doses. We propose that this modeling framework holds potential for model-informed drug development by quantitatively characterizing bacteria-phage dynamics using preclinical data. Furthermore, it may facilitate the interpretation of <i>in vivo</i> therapeutic outcomes through a mechanistic understanding derived from <i>in vitro
{"title":"Model-informed development of bacteriophage therapy: bridging <i>in vitro</i> and <i>in vivo</i> efficacy against multidrug-resistant <i>Pseudomonas aeruginosa</i>.","authors":"Jun Seok Cha, Kyungnam Kim, Hwa Jeong You, Dasom Kim, Hyun Hee Park, SuJin Heo, Choon Ok Kim, Byung Hak Jin, Dongeun Yong, Dongwoo Chae","doi":"10.1128/msystems.01384-25","DOIUrl":"10.1128/msystems.01384-25","url":null,"abstract":"<p><p>Bacteriophages are emerging as promising alternatives to antibiotics for multidrug-resistant (MDR) infections. However, their unique pharmacokinetic and pharmacodynamic (PKPD) properties arising from host-dependent amplification present challenges for dose selection and clinical translation. Here, we present a mechanistic PKPD model informed by <i>in vitro</i> kinetic assays and <i>in vivo</i> mouse studies of phage therapy targeting MDR <i>Pseudomonas aeruginosa</i>. The model extends the classical predator-prey model by addressing dormancy-related bacterial persistence and partitioning bacterial subpopulations based on phage susceptibility profiles. Simulations revealed a non-monotonous dose-exposure curve driven by dose-dependent reduction of phage replication and the importance of cross-resistance in selecting optimal phage cocktails. <i>In vivo</i>, host immunity was identified as a crucial component in inhibiting bacterial regrowth, with bistable outcomes dependent on initial bacterial load and immune competence. Dose-ranging simulations under varying immune statuses suggest that long-term bacterial load is solely determined by host immune function. However, higher doses transiently reduce bacterial load to a greater extent and thereby suppress immune activation. In immunocompetent hosts, phage cocktails can enhance maximal bacterial load reduction when administered at doses higher than a critical threshold. In conclusion, our PKPD framework enables optimal selection of phage cocktails and dosing regimens, supports rational design of first-in-human trials of phage therapy, and potentially advances model-informed drug development for replication-competent biologics.IMPORTANCEIn this study, we construct an integrative model of phage-bacteria dynamics and investigate whether its calibration to <i>in vitro</i> kinetic assay data can inform the rational design of phage therapy regimens and cocktails. Our findings demonstrate a dose range within which lower phage doses yield higher long-term exposure, presenting a fundamentally different framework for dose optimization. Analysis of phage cocktails reveals that combining phages with low cross-resistance delays the regrowth of phage-resistant bacteria <i>in vitro</i>. The extended <i>in vivo</i> model elucidates key differences between <i>in vitro</i> and <i>in vivo</i> outcomes and highlights the importance of the host's immune response in suppressing the growth of phage-resistant bacteria. Phage cocktails to combat phage resistance are therefore of less importance in immune-competent individuals but can enhance bacterial killing when administered at sufficiently high doses. We propose that this modeling framework holds potential for model-informed drug development by quantitatively characterizing bacteria-phage dynamics using preclinical data. Furthermore, it may facilitate the interpretation of <i>in vivo</i> therapeutic outcomes through a mechanistic understanding derived from <i>in vitro","PeriodicalId":18819,"journal":{"name":"mSystems","volume":"10 12","pages":"e0138425"},"PeriodicalIF":4.6,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12710366/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145768505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-17Epub Date: 2025-11-06DOI: 10.1128/msystems.01126-25
Mahbobeh Lesani, Caitlyn E Middleton, Tzu-Yu Feng, Jan Carlos Urbán Arroyo, Eli Casarez, Sarah E Ewald, Laura-Isobel McCall
Maladaptive host metabolic responses to infection are emerging as major determinants of infectious disease pathogenesis. However, the factors regulating these metabolic changes within tissues remain poorly understood. In this study, we used toxoplasmosis, as a prototypical example of a disease regulated by strong type I immune responses, to assess the relative roles of current local parasite burden, local tissue inflammation, and the microbiome in shaping local tissue metabolism during acute and chronic infections. Toxoplasmosis is a zoonotic disease caused by the parasite Toxoplasma gondii. This protozoan infects the small intestine and then disseminates broadly in the acute stage of infection, before establishing chronic infection in the skeletal muscle, cardiac muscle, and brain. We compared metabolism in 11 sampling sites in C57BL/6 mice during the acute and chronic stages of T. gondii infection. Strikingly, major spatial mismatches were observed between metabolic perturbation and local parasite burden at the time of sample collection for both disease stages. By contrast, a stronger association with indicators of active type I immune responses was observed, indicating a tighter relationship between metabolic perturbation and local immunity than with local parasite burden. Loss of signaling through the IL1 receptor in IL1R knockout mice was associated with reduced metabolic impact of infection. In addition, we observed significant changes in microbiota composition with infection and candidate microbial origins for multiple metabolites impacted by infection. These findings highlight the metabolic consequences of toxoplasmosis across different organs and potential regulators.IMPORTANCEInflammation is a major driver of tissue perturbation. However, the signals driving these changes on a tissue-intrinsic and molecular level are poorly understood. This study evaluated tissue-specific metabolic perturbations across 11 sampling sites following systemic murine infection with the parasite Toxoplasma gondii. Results revealed relationships between differential metabolite enrichment and variables, including inflammatory signals, pathogen burden, and commensal microbial communities. These data will inform hypotheses about the signals driving specific metabolic adaptation in acute and chronic protozoan infection, with broader implications for infection and inflammation in general.
{"title":"Spatially divergent metabolic impact of experimental toxoplasmosis: immunological and microbial correlates.","authors":"Mahbobeh Lesani, Caitlyn E Middleton, Tzu-Yu Feng, Jan Carlos Urbán Arroyo, Eli Casarez, Sarah E Ewald, Laura-Isobel McCall","doi":"10.1128/msystems.01126-25","DOIUrl":"10.1128/msystems.01126-25","url":null,"abstract":"<p><p>Maladaptive host metabolic responses to infection are emerging as major determinants of infectious disease pathogenesis. However, the factors regulating these metabolic changes within tissues remain poorly understood. In this study, we used toxoplasmosis, as a prototypical example of a disease regulated by strong type I immune responses, to assess the relative roles of current local parasite burden, local tissue inflammation, and the microbiome in shaping local tissue metabolism during acute and chronic infections. Toxoplasmosis is a zoonotic disease caused by the parasite <i>Toxoplasma gondii</i>. This protozoan infects the small intestine and then disseminates broadly in the acute stage of infection, before establishing chronic infection in the skeletal muscle, cardiac muscle, and brain. We compared metabolism in 11 sampling sites in C57BL/6 mice during the acute and chronic stages of <i>T. gondii</i> infection. Strikingly, major spatial mismatches were observed between metabolic perturbation and local parasite burden at the time of sample collection for both disease stages. By contrast, a stronger association with indicators of active type I immune responses was observed, indicating a tighter relationship between metabolic perturbation and local immunity than with local parasite burden. Loss of signaling through the IL1 receptor in IL1R knockout mice was associated with reduced metabolic impact of infection. In addition, we observed significant changes in microbiota composition with infection and candidate microbial origins for multiple metabolites impacted by infection. These findings highlight the metabolic consequences of toxoplasmosis across different organs and potential regulators.IMPORTANCEInflammation is a major driver of tissue perturbation. However, the signals driving these changes on a tissue-intrinsic and molecular level are poorly understood. This study evaluated tissue-specific metabolic perturbations across 11 sampling sites following systemic murine infection with the parasite <i>Toxoplasma gondii</i>. Results revealed relationships between differential metabolite enrichment and variables, including inflammatory signals, pathogen burden, and commensal microbial communities. These data will inform hypotheses about the signals driving specific metabolic adaptation in acute and chronic protozoan infection, with broader implications for infection and inflammation in general.</p>","PeriodicalId":18819,"journal":{"name":"mSystems","volume":" ","pages":"e0112625"},"PeriodicalIF":4.6,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12710369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145452371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}